My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    AIDS Behav. 2007 Mar;11(2):161-73.

    Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues.

    Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP.

    Department of Health Services, School of Public Health and Community Medicine, University of Washington, Seattle, WA 98105-1525, USA. pearsonc@u.washington.edu

    We explored methodological issues related to antiretroviral adherence assessment, using 6 months of data collected in a completed intervention trial involving 136 low-income HIV-positive outpatients in the Bronx, NY. Findings suggest that operationalizing adherence as a continuous (versus dichotomous) variable and averaging adherence estimates over multiple assessment points (versus using only one) explains greater variance in HIV-1 RNA viral load (VL). Self-reported estimates provided during a phone interview accounted for similar variance in VL as EDM estimates (R (2) = .17 phone versus .18 EDM). Self-reported adherence was not associated with a standard social desirability measure, and no difference in the accuracy of self-report adherence was observed for assessment periods of 1-3 days. Self-reported poor adherence was more closely associated with EDM adherence estimates than self-reported moderate and high adherence. On average across assessment points, fewer than 4% of participants who reported taking a dose of an incorrect amount of medication.

    PMID: 16804749 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read
    Write to the Help Desk